Word: drugging
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...giant Eli Lilly in federal court over a patent dispute that could have implications on the validity of certain kinds of biotechnology patents. The University and co-plaintiffs MIT, the Whitehead Institute for Biomedical Research, and Ariad Pharmaceuticals are seeking royalties from two of Eli Lilly’s drugs, Evista and Xigris. The institutions claim the drugs infringe on a patent they were jointly awarded in 2002. The trial began April 10 in U.S. District Court for the District of Massachusetts. Closing arguments are scheduled to take place tomorrow. The patent covers methods of treating diseases by modulating...
Current efforts to reduce tuberculosis (TB) death tolls in areas with high rates of HIV infection promote the development of drug-resistant strains of the deadly disease, according to a study by Harvard School of Public Health researchers. Instructor in Medicine Theodore H. Cohen and Assistant Professor of Epidemiology Megan Murray will publish their findings in the May 2 issue of the Proceedings of the National Academy of Sciences. The new study puts an emphasis on areas with high HIV rates and warns against the effects of indiscriminately using isoniazid on all patients, Cohen said. Isoniazid preventive therapy, a drug...
...watered-down lobbying reform bill House Republicans introduced this week that only temporarily bans private funding of House member travel and allows private interest groups to pay for meals and flights on corporate jets. She's also linking two hot-button issues to corruption: gas prices and prescription drugs. ?People know that Republicans are in charge in Washington and the culture of corruption is costing them whether it?s at the gas pump or in the prescription drug bill,? Daly says...
...Society of Clinical Oncology. The investigators are also writing a paper to submit to a research journal, but felt it would be unethical to withhold from the group that participated in the STAR trial their overall conclusion that raloxifene was the winner. The women will now find out which drug they were taking, and those on tamoxifen will be given the choice of either staying on that drug or switching to raloxifene...
...looking after these patients because he knew he had nothing to offer them." There were cracks of light in the 1990s, when researchers implicated a genetic mutation in a small subset of MND patients, and the pharmaceutical company Rhone-Poulenc Rorer launched riluzole (Rilutek), the first - and still only - drug approved for treating the disease. But no one was fooled into thinking that MND was anywhere near beaten...